Jam

Sable Offshore Corp. (SOC) priced an upsized public offering of 8.7 million shares at $29.50 each, targeting ~$256.5 million in gross proceeds. Underwriters J.P. Morgan, Jefferies, and TD Cowen secured an option for an additional 1.3 million shares. Proceeds will fund capital expenditures and corporate needs, with closure expected by May 23 pending approvals. The Houston-based firm, focused on California’s Santa Ynez Unit offshore assets, highlights operational expertise amid regulatory and ESG challenges. Analysts note the pricing reflects cautious optimism as energy equities rebound, though supply chain and permitting risks persist. SEC-declared effective May 1, the offering expands distribution through co-managers including Benchmark Company and Pickering Energy Partners.

Barton Gold Holdings (ASX: BGD) launched a drilling campaign in South Australia’s Gawler Craton to explore high-grade gold-silver deposits. The company, holding 1.7Moz gold and 3.1Moz silver JORC-compliant resources, maintains full ownership of regional processing infrastructure, including the Challenger mill. Supported by certified geologists, Barton targets 150,000oz annual production from its 64Mt resource base (0.83g/t Au). Amidst gold price surges due to geopolitical and inflation factors, the strategic assets position Barton for growth, though exploration risks and market volatility persist.

Oyster Enterprises II Acquisition Corp upsized its IPO to $220 million (22M units at $10), listing on Nasdaq as OYSEU on May 22, 2025. The SPAC replaces traditional warrants with fractional share rights to minimize investor dilution, targeting AI, blockchain, media, and real estate sectors. Led by tech-linked executives including Divya Narendra, it leverages a $253 million potential warchest with underwriters’ 15% over-allotment option. While benefiting from recovering SPAC market trends and high-growth tech sectors, challenges include competition for acquisitions, undisclosed targets, and prolonged merger timelines prevalent in the post-2023 SPAC landscape. BTIG serves as sole bookrunner.

Senseonics Holdings raised $77.8 million via a public offering (115M shares at $0.50) and a $20.3M private placement from Abbott Laboratories, which acquired a 4.99% stake. The funds will accelerate U.S. commercialization of its Eversense 365, a 12-month implantable glucose monitor, and support innovation. While the capital extends operations through 2026, significant share dilution and low pricing reflect market skepticism. Abbott’s investment signals strategic interest in implantable CGM tech, despite maintaining dominance with its FreeStyle Libre system. Key challenges include securing Medicare coverage and expanding beyond niche medical markets.

Sharps Technology (NASDAQ: STSS) CEO Robert Hayes will present at the Aegis Capital Virtual Conference on May 22, 2025, highlighting the company’s advancements in smart-safety syringes. These innovations include ultra-low waste systems and specialized polymer technology designed to enhance drug stability, targeting the $10B+ prefilled syringe market. The Hungary-based manufacturing facility supports scalable production for European and transatlantic markets. Sharps’ patented dual safety mechanisms reduce drug waste by up to 20%, addressing cost-efficiency demands in healthcare. The live webcast begins at 1:00 p.m. ET, with forward-looking statements noting potential regulatory and market risks.

The PG&E Corporation Foundation’s Better Together Nature Positive Innovation Grant program offers $500,000 ($100,000 each across five regions) to fund community-driven environmental projects in Central and Northern California. Targeting air quality, land restoration, and water conservation, the grants support government, educational, and nonprofit initiatives, prioritizing disadvantaged communities. Applications close July 18, 2025. Funded by PG&E shareholders, the program builds on past successes like wildfire resilience efforts and regenerative farming support. Projects at any stage—planning, design, or implementation—are eligible. PG&E, serving 16 million Californians, aims to amplify climate resilience through collaborative, scalable solutions.

Freddie Mac priced its $284.2 million SLST Series 2025-1, comprising $262.9 million in government-backed senior certificates and $21.3 million in non-guaranteed subordinate notes, to enhance mortgage portfolio liquidity and share risk with private investors. Collateralized by 1,891 seasoned mortgages (≤150 days delinquent), the deal settles May 28, 2025. Part of its structured credit strategy, Freddie Mac has securitized $80.3 billion since 2011, aided by advisors BofA Securities and Wells Fargo. Senior tranches target low-risk investors, while subordinated notes offer higher returns. The transaction reflects ongoing efforts to optimize capital, reduce balance sheet risk, and comply with post-2008 reforms.

Evofem Biosciences partners with UAE-based Pharma 1 to expand access to FDA-approved SOLOSEC® (secnidazole) for bacterial vaginosis and trichomoniasis in the Middle East. The agreement grants Pharma 1 exclusive commercialization rights, with plans to file for UAE regulatory approval by mid-2025. Evofem will supply SOLOSEC at cost-plus pricing, leveraging Pharma 1’s distribution network. Targeting a region with high BV prevalence (25%–41% in MENA), the single-dose therapy addresses compliance challenges linked to multi-day treatments. The deal aligns with Evofem’s global expansion strategy, building on prior collaborations for its contraceptive PHEXXI®, and aims to reduce health risks like HIV transmission and preterm births in underserved populations.

TreeHouse Foods, a leading North American private-label food manufacturer, will participate in two investor conferences in June 2025. On June 4, executives will present at the William Blair Growth Conference in Chicago, with a live webcast on their investor site. They will also attend the Jefferies Consumer Conference in Nantucket on June 17, conducting meetings to highlight growth strategies and market leadership in the $150 billion private-label sector. The company emphasizes innovation, affordability, and operational efficiency to meet consumer demand for value-driven products. Updates and replays will be available via their investor relations portal.

Bilibili launched a $500M convertible note offering (expandable to $575M) with a Delta Offering strategy to hedge investor positions using borrowed shares, alongside a $100M share buyback. The proceeds will fund content expansion and user growth, leveraging convertible debt’s lower rates while delaying equity dilution. The share repurchase signals management confidence, while the Delta mechanism mitigates near-term stock pressure. Risks include potential 3-5% future shareholder dilution and increased leverage. The structured approach balances capital acquisition with market stability amidst China’s tightening tech fundraising regulations, targeting competition in Gen-Z-focused video platforms.